Home › Blog › Comparison

Comparison

Panax ginseng vs maca: which has the better evidence for men?

Two ingredients with real trials behind them, compared honestly on what each one moved.

Published 09 September 2026 · 8 min read · by the HoneyPower Review desk

If you strip a male vitality blend back to the ingredients with real randomised human trials behind them, you are usually left with two: Panax ginseng and maca. They are on almost every label, including HoneyPower's, and they work on different things.

Here is the honest comparison.

Ginseng: the bigger file, the more sobering summary

Panax ginseng has the largest evidence base of anything in this category, and the best summary of it is also the most deflating.

The 2021 Cochrane review pooled nine studies covering 587 men. Individual trials were encouraging. The pooled effect on erectile function came out below the review's own threshold for a difference a man would notice, and the authors said so again in a follow-up summary.

That is what a mature evidence base often looks like: promising small trials, and a pooled result that is real but smaller than the marketing implies.

The doses are worth holding onto. 1,000 mg three times daily for twelve weeks. Four 350 mg tablets daily for eight weeks. Gram-scale, every time.

Ginseng also has the fatigue literature the category likes to cite, and it is genuinely mixed — positive in chronic fatigue and rheumatic disease, flat in advanced cancer.

And one hard caution: American ginseng at 1 g twice daily reduced warfarin's effect in a randomised trial, with a supporting report in patients with replacement heart valves. If you take an anticoagulant, this is a conversation with your prescriber, not a judgement call.

Maca: the smaller file, the cleaner finding

Maca's evidence base is smaller and, in one important respect, clearer.

The 2002 trial in adult healthy men gave 1,500 mg or 3,000 mg daily. Self-reported sexual desire rose. Serum testosterone did not change — and the paper's title says so out loud, which is rarer than it should be.

That separation matters enormously for how you read this whole category. It shows that desire and testosterone are not the same variable, and that a product can move one without touching the other. Most marketing in this space conflates them deliberately.

The dose-finding study is the other one worth knowing: 1.5 g against 3.0 g, and only the 3 g arm moved. That is an unusually direct answer to "does the amount matter", and the answer is yes.

The systematic review found the trials small but consistent on desire, and a 175-person trial at 3 g for twelve weeks supports the safety side.

So which one?

They answer different questions, which is why blends carry both.

• If your interest is desire, maca has the cleaner and more specific finding, and the dose-response data to go with it.
• If your interest is erectile function, ginseng has the larger file — with the caveat that the best summary of that file is underwhelming.
• If your interest is fatigue, ginseng is the only one of the two with any literature at all, and it is mixed.
• If you take an anticoagulant, ginseng is the one to raise with your prescriber first.

The thing that applies to both

Every dose above is gram-scale. Two capsules of a six-ingredient blend carry roughly a gram and a half in total, shared six ways. Whatever a blend contains of either plant, it is not the trial dose — which is the central point of our ingredient breakdown and of the dosage table in the main review.

If you want one of these at a studied amount, a single-ingredient product with a printed number on the label will get you there more cheaply and more verifiably than any blend will.